-
41
Biotin interference with laboratory test results
Published 2024-01-01Subjects: Get full text
Article -
42
FDA’s approval of resmetirom (Rezdiffra): a breakthrough in MASH management
Published 2024-12-01Subjects: Get full text
Article -
43
A remarkable and durable response to tislelizumab treatment of an anaplastic thyroid carcinoma without targetable genomic alterations: a case report
Published 2025-02-01Subjects: “…anaplastic thyroid carcinoma…”
Get full text
Article -
44
-
45
Histogram of Apparent Diffusion Coefficient to Evaluate the Activity of Thyroid‐Associated Ophthalmopathy
Published 2025-01-01Subjects: Get full text
Article -
46
-
47
Proteomics unveil candidate biomarkers and pathogenesis of subacute thyroiditis
Published 2025-02-01Subjects: “…subacute thyroiditis…”
Get full text
Article